Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells W Yan, X Wu, W Zhou, MY Fong, M Cao, J Liu, X Liu, CH Chen, O Fadare, ... Nature cell biology 20 (5), 597-609, 2018 | 340 | 2018 |
Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts X Liu, M Cao, M Palomares, X Wu, A Li, W Yan, MY Fong, WC Chan, ... Breast Cancer Research 20, 1-12, 2018 | 65 | 2018 |
Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia J Wang, N Mou, Z Yang, Q Li, Y Jiang, J Meng, X Liu, Q Deng British journal of haematology 191 (2), 212-222, 2020 | 43 | 2020 |
Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth M Cao, R Isaac, W Yan, X Ruan, L Jiang, Y Wan, J Wang, E Wang, ... Nature cell biology 24 (6), 954-967, 2022 | 38 | 2022 |
Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma G Dong, X Liu, L Wang, W Yin, A Bouska, Q Gong, K Shetty, L Chen, ... Leukemia 36 (8), 2064-2075, 2022 | 23 | 2022 |
Multi-kinase inhibitor with anti-p38γ activity in cutaneous T-cell lymphoma XH Zhang, S Nam, J Wu, CH Chen, X Liu, H Li, T McKeithan, Q Gong, ... Journal of Investigative Dermatology 138 (11), 2377-2387, 2018 | 19 | 2018 |
Cancer‐secreted miRNAs regulate amino‐acid‐induced mTORC1 signaling and fibroblast protein synthesis MY Fong, W Yan, M Ghassemian, X Wu, X Zhou, M Cao, L Jiang, J Wang, ... EMBO reports 22 (2), e51239, 2021 | 16 | 2021 |
Humanized anti‐CD19 chimeric antigen receptor‐T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection R Cui, C Lyu, Q Li, Y Jiang, N Mou, Z Yang, X Liu, Q Deng, L Li Hematological Oncology 39 (1), 75-86, 2021 | 16 | 2021 |
Polarized secretion of extracellular vesicles by mammary epithelia AR Chin, W Yan, M Cao, X Liu, SE Wang Journal of mammary gland biology and neoplasia 23, 165-176, 2018 | 16 | 2018 |
Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1 G Dong, Y Li, L Lee, X Liu, Y Shi, X Liu, A Bouska, Q Gong, L Kong, ... Haematologica 106 (9), 2427, 2021 | 8 | 2021 |
PRDM1 decreases sensitivity of human NK cells to IL2-induced cell expansion by directly repressing CD25 (IL2RA) B Akman, X Hu, X Liu, T Hatipoğlu, H You, WC Chan, C Küçük Journal of Leucocyte Biology 109 (5), 901-914, 2021 | 5 | 2021 |
Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma X Liu, J Ning, X Liu, WC Chan Cancers 14 (15), 3716, 2022 | 4 | 2022 |
Selective estrogen receptor modulator BC-1 activates antioxidant signaling pathway in vitro via formation of reactive metabolites B Yu, Z Mai, X Liu, Z Huang Acta Pharmacologica Sinica 34 (3), 373-379, 2013 | 3 | 2013 |
Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines J Zhang, T Wang, K Shetty, S Alkan, S Xu, Q Gong, X Liu, Y Li, Z Hu, ... Blood Advances 6 (17), 5067-5071, 2022 | 2 | 2022 |
TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia YR Zhang, Z Yu, WJ Xiong, XX Liu, HM Liu, R Cui, Q Wang, WM Chen, ... Chinese Medical Journal 133 (17), 2090-2097, 2020 | 2 | 2020 |
VAV1-GFP Fusion Protein Generated by Intron-Based Genome Editing through Crispr/Cas9 Leads to Spontaneous Activation in TCR Signaling X Liu, Y Li, X Liu, W Qi, J Zhang, K Shetty, J Iqbal, WC Chan Blood 136, 27-28, 2020 | 1 | 2020 |
The Role of Mir-218 in Breast Cancer Bone Metastasis X Liu City of Hope's Irell & Manella Graduate School of Biomedical Sciences, 2018 | 1 | 2018 |
The Influence of TET2 and/or DNMT3A Knockout on the 5hmC Levels and Growth Characteristics of Modified Human Primary CD4 T Cells after Activation R Yang, X Liu, J Zhang, Y Li, K Chew, C Wu, JM Zain, JY Song, WG Lone, ... Blood 142, 2775, 2023 | | 2023 |
PRDM1 Deletion and STAT3 Mutations Cooperatively Promote CD8+ T-Cell and NK-Cell Growth in Vitro X Liu, K Shetty, Y Li, J Zhang, AC Bouska, J Iqbal, G Inghirami, WC Chan Blood 140 (Supplement 1), 5913-5913, 2022 | | 2022 |
Co-Occurrence of TP53/PTEN and CCR4 genetic Alteration Deregulates TH-Cell Differentiation and Drives TH2-like Lymphomagenesis and T-Cell Signaling DT Jochum, WG Lone, AC Bouska, X Liu, J Yu, C Amador, S Sharma, ... Blood 140 (Supplement 1), 2040-2041, 2022 | | 2022 |